Highlights from APA 2021: Tardive Dsykinesia – eBook
APA 2021 Annual Meeting Featuring Valbenazine for Tardive Dyskinesia Demonstrates Robust &...
APA 2021
Valbenazine: Cost-Effective, Efficacious Treatment for Tardive Dyskinesia
Since the 1950s, when the movement disorder tardive dyskinesia (TD) was first described, several drugs have been studied for potential effectiveness or used off-label for the treatment of TD, but none provided clear evidence of...
PhysQuiz on APA 2021: Tardive Dyskinesia
Are you caught up on trials on tardive dyskinesia presented on APA 2021? Test your knowledge! 1. A...
Patients with TD More Worried about Mental Health than Movement
Although assessing and reducing the severity of tardive dyskinesia (TD)—a persistent and potentially disabling movement disorder linked with exposure to antipsychotics and other dopamine receptor blocking agents—is crucial for...
Challenges in Treating Tardive Dyskinesia
By: Cecilia Peterson; Amanda Glazar; Chirag Shah; Prakash Masand; Michael Lemon Introduction: Tardive Dyskinesia (TD) refers to abnormal, involuntary, choreoathetoid movements of the tongue, lips, face, trunk, and extremities...
PhysQuiz Answers! APA 2021: Tardive Dyskinesia
How did you do? 1) A post-hoc analysis of AIMS data from a long-term valbenazine study, KINECT 4 to assess the patterns of improvement of patients with TD found that what percentage of patients receiving valbenazine met...
Valbenazine for Tardive Dyskinesia Demonstrates Robust & Long-Term Improvement
Chirag Shah, PharmD Head, Strategic Publications & Medical Education Medical Affairs,...
Tardive Dyskinesia Often Treated Incorrectly
Researchers who sought to understand the evolving continuing medical education (CME) needs of...
Six Best Practices for Telepsychiatry and Tardive Dyskinesia
In July 2020, experts participated in individual semi-structured qualitative interviews about how tardive Dyskinesia (TD) is diagnosed and treated in real-world settings. A virtual roundtable follow-up was conducted in November...
APA 2021: Does Cognitive Behavioral Therapy Impact Dementia?
Researchers presented the findings of cognitive behavioral therapy (CBT) benefits on anxiety, depression, and quality of life in patients with mild cognitive impairment (MCI) and dementia “Today, no reviews have analyzed...
Many Psychiatrists Incorrectly Treating Tardive Dyskinesia
By: Chirag Shah; Shereta Wiley; Sylvie Stacy; Leslie Lundt In a poster session, researchers sought to understand the evolving continuing medical education (CME) needs of psychiatrists managing patients with tardive dyskinesia...
APA 2021: Is Aripiprazole-Induced Tardive Dyskinesia an Unrecognized Threat?
As an involuntary movement disorder resulting from exposure to dopamine antagonists, tardive dyskinesia (TD) classically manifests as involuntary oro-bucco-lingual and facial dyskinesia, as well as limb, trunk, and respiratory...
